Target intelligence / Profile preview

Long non-coding RNA transcript (lncRNA)

Target
lncRNA
Molecular classification
Other
01

Overview

A **long non-coding RNA transcript (lncRNA)** is an RNA molecule typically longer than 200 nucleotides that is not translated into protein[1][7][9]. lncRNAs are a diverse group of transcripts transcribed by RNA polymerase II, and include various subtypes such as intergenic, intronic, sense, and antisense lncRNAs[1][4]. They are involved in the regulation of gene expression on multiple levels (epigenetic, transcriptional, post-transcriptional), chromatin organization, maintenance of genomic stability, and in cellular responses to external stimuli[3][4][5][6][8]. Dysregulated lncRNA expression has been implicated in numerous diseases, including cancers, neurodegenerative and cardiovascular disorders, and immune-related conditions[3][4][5]. While individual lncRNAs (e.g., HOTAIR, MALAT1, Xist) can serve as important biomarkers or therapeutic targets, "long non-coding RNA transcript" refers generically to a class of molecules and not to a specific targetable entity[3][6][9].

Other names
long ncRNAlncRNAlong noncoding RNAlarge intergenic non-coding RNA (lincRNA)long intervening non-coding RNA
02

Biological functions

Gene expression regulationChromatin modificationEpigenetic regulationRNA splicing and processingCellular signalingMaintenance of genome stabilityDNA damage response
03

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationInfectionOther
04

Safety considerations

Off-target effects and unanticipated regulation of gene expression if targeted, but these are concerns for specific lncRNAs, not for "long non-coding RNA transcript" as a generic class[3][4].
05

Biomarkers

Some lncRNAs (e.g., HOTAIR, MALAT1, Xist) are used as biomarkers in cancer and other diseases, but "long non-coding RNA transcript" is not itself a biomarker[3][4][6].

Beyond the preview

Go deeper on Long non-coding RNA transcript (lncRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long non-coding RNA transcript (lncRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call